UBS expanded its reported position in BlackRock's iShares Bitcoin Trust to roughly 2.5 million shares as of June 30, 2026, up from approximately 549,000 shares at the end of 2025. The Swiss bank disclosed the holdings in a Form 13F filed with the SEC on Aug. 13. Measured by share count, the position grew about 355 percent during the first half of the year.

The reported dollar value of the stake rose from roughly $27 million at year-end 2025 to close to $90 million at June 30, a gain of about 230 percent. The gap between the 355 percent share-count increase and the 230 percent value increase reflects IBIT's performance over the period: BlackRock's fund data show the ETF's market-price return fell 32.95 percent during the six months through June 30. The value increase came from UBS adding shares, not from price appreciation.

Separate data show UBS also expanded its call-option exposure tied to IBIT by more than 24-fold during the quarter, reaching 1.95 million underlying shares as of June 30. Call options give the holder the right to buy shares at a set price before expiration—a structure that allows for leveraged participation in price moves without directly holding the underlying asset. The combination of direct share accumulation and a sharp increase in call-option exposure points to a deliberate expansion of IBIT-linked risk across UBS's reported book.

A Form 13F requires institutional investment managers exercising discretion over at least $100 million in certain securities to file quarterly holdings reports with the SEC. The filings cover positions held at the end of each quarter, so UBS's actual exposure as of Aug. 13—the filing date—is not captured in this document. UBS may have changed its IBIT allocation in any direction between June 30 and when it submitted the form.

The filing also does not establish that UBS deployed $90 million of its own corporate capital into IBIT. A 13F aggregates all securities over which the institution exercises investment discretion, which includes positions held in client, advisory, wealth-management and asset-management accounts. The disclosure confirms UBS reported control over those shares for filing purposes; it does not identify the beneficial owners or the investment instructions that drove the purchases.

Even at face value, the $90 million position is small against UBS's overall asset base. The bank reported $7.3 trillion in group invested assets in its second-quarter results published July 29—a record level. Its Global Wealth Management division pulled in $36 billion in net new assets during the second quarter alone and $73 billion during the first half of 2026. UBS also posted $2.8 billion in net profit for Q2 and $5.8 billion for the first six months of the year.

UBS has separately been building out digital-asset access for wealthy clients. In Jan. 2026, the bank announced plans to give select high-net-worth and ultra-high-net-worth private banking clients exposure to cryptocurrency investments. That initiative followed earlier internal restrictions the bank had placed around how it handled U.S. spot Bitcoin ETFs, making the IBIT position growth a visible outcome of a deliberate change in product strategy.

The IBIT filing lands while Bitcoin trades at $62,828, down 0.4 percent over the past 24 hours, and the Crypto Fear and Greed Index sits at 34—deep in fear territory. UBS was adding shares through a period when IBIT's market-price return dropped nearly 33 percent, meaning the bank's wealth and asset-management operations were buying into weakness rather than chasing strength.

BlackRock's IBIT is the dominant U.S. spot Bitcoin ETF by assets under management and typically accounts for the largest share of daily ETF volume in the space. Spot Bitcoin ETFs received SEC approval in January 2024, and the market has been trading for more than two years. UBS's expanded footprint in IBIT—whether through client mandates, proprietary positions, or a mix—adds to a growing list of large financial institutions that have built measurable exposure to the product since approval.

The 13F is a lagging snapshot, but the scale of the move—nearly 2 million shares added in six months, on top of a 24-fold increase in call-option exposure—points to a sustained and deliberate buildup rather than a one-quarter anomaly. Whether the position has grown, shrunk, or held steady since June 30 will become visible when UBS files its next quarterly 13F covering the period ending Sept. 30.